Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 291 of 1,261
  1. US 11207283

    Inactivators of toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria

    Northwestern University · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  2. US 11207339

    Targeted cancer therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  3. US 11207315

    Emetine compounds for treatment and prevention of flavivirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  4. US 11207322

    Method and composition related to combination therapy for addiction

    The Board of Regents of the University of Texas System · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  5. US 11207379

    Peptides with anti-cancer activity

    IDP DISCOVERY PHARMA, S.L. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  6. US 11208662

    RNAi inhibition of alpha-ENaC expression

    Arrowhead Pharmaceuticals, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  7. US 11208650

    Modulators of IRF5 expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  8. US 11208640

    Modulating human Cas9-specific host immune response

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  9. US 11208493

    Internalizing human monoclonal antibodies targeting prostate and other cancer cells

    The Regents of the University of California · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  10. US 11208479

    CX43 hemichannel antibodies and methods of use

    The Board of Regents of the University of Texas System · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  11. US 11208470

    DNA antibody constructs and method of using same

    Inovio Pharmaceuticals, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  12. US 11208456

    Anti-KRAS-G12D T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  13. US 11208634

    Deimmunized therapeutic compositions and methods

    Regents of the University of Minnesota · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  14. US 11208458

    Compositions and methods for internalizing enzymes

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  15. US 11208416

    Selective inhibitors of protein arginine methytransterase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  16. US 11208413

    Pyrimidopyrimidinones useful as wee-1 kinase inhibitors

    ALMAG DISCOVERY LIMITED · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  17. US 11208418

    Nitrogenous tricyclic compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  18. US 11208385

    N-substituted imidazole carboxylate compound, preparation method and use

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  19. US 11208411

    Compositions and methods for treating parasitic diseases

    The Regents of the University of California · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  20. US 11208397

    Small molecule antagonists of sumo related modification of CRMP2 and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  21. US 11208330

    Identification and optimization of carbon radicals on hydrated graphene oxide for ubiquitous antibacterial coatings

    The Regents of the University of California · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  22. US 11207687

    Artificial cells

    University College Cardiff Consultants Limited · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  23. US 11207429

    Method and compositions for orally administered contrast agents for MR imaging

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  24. US 11207396

    Immunization to protect against adverse cardiac events relating to pneumococcal infection

    The Board of Regents of the University of Texas System · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.